Wenfeng Gou

1.4k total citations
67 papers, 1.1k citations indexed

About

Wenfeng Gou is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wenfeng Gou has authored 67 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 17 papers in Oncology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wenfeng Gou's work include Cancer-related gene regulation (11 papers), Lung Cancer Treatments and Mutations (7 papers) and RNA modifications and cancer (6 papers). Wenfeng Gou is often cited by papers focused on Cancer-related gene regulation (11 papers), Lung Cancer Treatments and Mutations (7 papers) and RNA modifications and cancer (6 papers). Wenfeng Gou collaborates with scholars based in China, Japan and United States. Wenfeng Gou's co-authors include Hua‐chuan Zheng, Yasuo Takano, Yang Zhao, Shuang Zhao, Yasuo Takano, Li‐Jun Xiao, Daiying Zuo, Shuang Zhao, Hongzhi Sun and Shuo Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Wenfeng Gou

63 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenfeng Gou China 23 726 277 190 150 148 67 1.1k
Hyeon‐Ok Jin South Korea 24 853 1.2× 203 0.7× 277 1.5× 120 0.8× 104 0.7× 50 1.3k
Lei Bi China 17 543 0.7× 218 0.8× 215 1.1× 94 0.6× 123 0.8× 46 977
Yancun Yin China 18 654 0.9× 198 0.7× 232 1.2× 144 1.0× 98 0.7× 33 1.2k
Feng‐Hou Gao China 23 886 1.2× 346 1.2× 253 1.3× 101 0.7× 117 0.8× 50 1.4k
Napoleón Navarro‐Tito Mexico 20 595 0.8× 296 1.1× 432 2.3× 117 0.8× 78 0.5× 53 1.2k
Kui Sheng Chen China 2 606 0.8× 216 0.8× 241 1.3× 65 0.4× 144 1.0× 5 1.0k
Caiyu Lin China 17 680 0.9× 443 1.6× 262 1.4× 97 0.6× 261 1.8× 43 1.1k
Liyan Chen China 18 581 0.8× 160 0.6× 164 0.9× 69 0.5× 113 0.8× 33 851
Dong-Hun Bae Australia 13 732 1.0× 179 0.6× 122 0.6× 102 0.7× 165 1.1× 16 1.3k
Ajda Çoker Gürkan Türkiye 19 502 0.7× 181 0.7× 124 0.7× 163 1.1× 68 0.5× 69 914

Countries citing papers authored by Wenfeng Gou

Since Specialization
Citations

This map shows the geographic impact of Wenfeng Gou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenfeng Gou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenfeng Gou more than expected).

Fields of papers citing papers by Wenfeng Gou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenfeng Gou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenfeng Gou. The network helps show where Wenfeng Gou may publish in the future.

Co-authorship network of co-authors of Wenfeng Gou

This figure shows the co-authorship network connecting the top 25 collaborators of Wenfeng Gou. A scholar is included among the top collaborators of Wenfeng Gou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenfeng Gou. Wenfeng Gou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gou, Wenfeng, et al.. (2025). Target Discovery Driven by Chemical Biology and Computational Biology. The Chemical Record. 25(3). e202400182–e202400182.
2.
Gou, Wenfeng, Mingwei Ma, Ying Cui, et al.. (2025). Investigation of the fingerprint-activity relationship of Tremella fuciformis polysaccharides and its mitigating effect on radiation-induced intestinal injury. International Journal of Biological Macromolecules. 304(Pt 1). 140849–140849. 1 indexed citations
3.
Wang, Ao, Wenfeng Gou, Feifei Xu, et al.. (2025). Qingyi decoction and its active ingredients ameliorate acute pancreatitis by regulating acinar cells and macrophages via NF-κB/NLRP3/Caspase-1 pathways. Phytomedicine. 139. 156424–156424. 7 indexed citations
4.
Wang, Ao, Xuefei Wang, Wenfeng Gou, et al.. (2025). Mesenchymal Stem Cells Derived from Different Adipose Tissue Depots Ameliorate Severe Acute Pancreatitis by Inhibiting NF-κB/NLRP3/Caspase-1 Pathways. Stem Cell Reviews and Reports. 21(7). 2200–2217. 1 indexed citations
5.
Hou, Yue, Yue Shang, Feifei Xu, et al.. (2024). Ionizing radiation induces neurotoxicity in Xenopus laevis embryos through neuroactive ligand-receptor interaction pathway. Environmental Research. 256. 119237–119237. 7 indexed citations
6.
Dai, Dong, Wenfeng Gou, Yanli Li, et al.. (2024). Novel CDK19-Targeted Radiotracers: A Potential Design Strategy to Improve the Pharmacokinetics and Tumor Uptake. Journal of Medicinal Chemistry. 67(8). 6726–6737. 3 indexed citations
7.
Gou, Wenfeng, et al.. (2024). Label-free Protein Analysis Methods for Active Compound Targets Identification. Acta Chimica Sinica. 82(6). 629–629. 1 indexed citations
8.
Meng, Fancui, Yu Shi, Zhenyu Peng, et al.. (2024). Bazedoxifene analogs as potential WDHD1 degraders and antitumor agents: Synthesis, evaluation and molecular dynamics simulation studies. Drug Development Research. 85(1). e22155–e22155. 1 indexed citations
9.
Gou, Wenfeng, et al.. (2024). Mass spectrometry imaging for unearthing and validating quality markers in traditional Chinese medicines. Chinese Herbal Medicines. 17(1). 31–40. 2 indexed citations
10.
Wei, Huiqiang, Wenfeng Gou, Jun Gao, et al.. (2022). Novel PHD2/HDACs hybrid inhibitors protect against cisplatin-induced acute kidney injury. European Journal of Medicinal Chemistry. 230. 114115–114115. 7 indexed citations
11.
Gou, Wenfeng, et al.. (2022). Molecular mechanisms of isoflavone puerarin against cardiovascular diseases: What we know and where we go. Chinese Herbal Medicines. 14(2). 234–243. 27 indexed citations
12.
Bi, Changfen, et al.. (2021). Phosphate group functionalized magnetic metal–organic framework nanocomposite for highly efficient removal of U(VI) from aqueous solution. Scientific Reports. 11(1). 24328–24328. 23 indexed citations
13.
Wei, Huiqiang, Jingcheng Yu, Wenfeng Gou, et al.. (2021). Discovery of novel triazole compounds as selective IL-1β releasement inhibitors. Bioorganic & Medicinal Chemistry Letters. 53. 128415–128415. 4 indexed citations
14.
Gou, Wenfeng, Zengqiang Li, Xiaobo Xu, et al.. (2020). ZX-29, a novel ALK inhibitor, induces apoptosis via ER stress in ALK rearrangement NSCLC cells and overcomes cell resistance caused by an ALK mutation. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1867(7). 118712–118712. 6 indexed citations
15.
16.
Guo, Ming, Daiying Zuo, Jun‐Long Zhang, et al.. (2018). Dual potent ALK and ROS1 inhibitors combating drug-resistant mutants: Synthesis and biological evaluation of aminopyridine-containing diarylaminopyrimidine derivatives. European Journal of Medicinal Chemistry. 158. 322–333. 24 indexed citations
17.
Zhang, Meiying, Wenfeng Gou, Shuang Zhao, et al.. (2014). Beclin 1 Expression is Closely Linked to Colorectal Carcinogenesis and Distant Metastasis of Colorectal Carcinoma. International Journal of Molecular Sciences. 15(8). 14372–14385. 36 indexed citations
18.
Xia, Pu, Wenfeng Gou, Jinjin Wang, et al.. (2013). Distinct Radiosensitivity of Lung Carcinoma Stem-Like Side Population and Main Population Cells. Cancer Biotherapy and Radiopharmaceuticals. 28(6). 471–478. 14 indexed citations
19.
Gou, Wenfeng, et al.. (2013). Aberrant SERCA3 expression during the colorectal adenoma-adenocarcinoma sequence. Oncology Reports. 31(1). 232–240. 14 indexed citations
20.
Xu, Xiaoyan, Wenfeng Gou, Xue Yang, et al.. (2012). Aberrant SERCA3 expression is closely linked to pathogenesis, invasion, metastasis, and prognosis of gastric carcinomas. Tumor Biology. 33(6). 1845–1854. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hyeon‐Ok Jin Breakdown of academic impact, for papers by Lei Bi Breakdown of academic impact, for papers by Yancun Yin Breakdown of academic impact, for papers by Feng‐Hou Gao Breakdown of academic impact, for papers by Napoleón Navarro‐Tito Breakdown of academic impact, for papers by Kui Sheng Chen Breakdown of academic impact, for papers by Caiyu Lin Breakdown of academic impact, for papers by Liyan Chen Breakdown of academic impact, for papers by Dong-Hun Bae Breakdown of academic impact, for papers by Ajda Çoker Gürkan
Rankless by CCL
2026